SecBot SecBot
EFFECT ·Filed Sep 18, 2026

BKHA

Black Hawk Acquisition Corp
NEUTRAL
Impact 5/10
Horizonweeks Processed1mo ago SEC9999999995-26-002988
IPO/offering going effective
Actionable Insight • Neutral

The S-4 effectiveness removes a regulatory hurdle for the SPAC merger. Watch for the shareholder vote date and the closing announcement, which typically follow within weeks. Post-merger, the combined entity's trading symbol and capital structure will be key catalysts.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
BKHA ▼ -49.87% at T+20d
NEUTRAL call -49.87% · α vs SPY -50.08% · entry $11.99 → $6.01
Next anchor: T+60d in 7w
Latest observation: T+25 -55.05% FF3 residual α
Entry = T+0 close
Sep 18, 2026
via day close
T+1d
0.00%
call 0.00% · α -1.55%
$11.99
settled 5w ago
T+5d
+2.34%
call +2.34% · α +1.07%
$12.27
settled 5w ago
T+20d
-49.87%
call -49.87% · α -50.08%
$6.01
settled 11d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

The SEC declared effective a registration statement (S-4) filed by Black Hawk Acquisition Corp and Vesicor Therapeutics, Inc., clearing the way for a business combination between the two entities. This is a procedural milestone that allows the transaction to proceed toward closing.

Key Facts

  • Effectiveness date: September 17, 2026
  • Registration statement file number: 333-292402 (Black Hawk Acquisition Corp) and 333-292402-01 (Vesicor Therapeutics, Inc.)
  • S-4 registration — business combination transaction between a SPAC (Black Hawk) and a biotech (Vesicor Therapeutics)
  • Both filers classified under SIC 2836 (Biological Products)

Financial Impact

No financial figures disclosed in the EFFECT notice; the underlying S-4 registration statement was not provided.

Risk Factors

  • Shareholder approval of the business combination is not guaranteed
  • Post-merger dilution and lockup expirations could pressure the stock
  • Vesicor Therapeutics is a pre-revenue biotech — clinical-stage risk remains

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002988
Document: 9999999995-26-002988-index.html9999999995-26-002988
Document: 9999999995-26-002988.txt9999999995-26-002988
8 reports for BKHA
Performance horizon
33% Hit rate @ T+20 1 of 3 directional calls Went positive at some point 1 of 3 best @ T+20▲ +65.79%Sep 21, 2026
Filters
Rows
Reports for BKHA — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
8-K
NEUTRAL ★ 2/10
$5.12awaiting T+20—$5.40 (+5.47%)
Oct 7, 2026
19d ago
SC 13G/A
NEUTRAL ★ 3/10
$13.00awaiting T+20—$5.40 (−58.46%)
Sep 24, 2026
4w ago
8-K
MIXED ★ 6/10
$12.27 $5.40▼ −55.99%▼ −54.51%$5.40 (−55.99%)
Sep 21, 2026
5w ago
424B4
BEARISH ★ 7/10
$12.10 $4.14▲ +65.79%▲ +65.23%$5.40 (+55.37%)
Sep 18, 2026
5w ago
EFFECT
NEUTRAL ★ 5/10
$11.99 $6.01▼ −49.87%▼ −50.08%$5.40 (−54.96%)
Sep 4, 2026
7w ago
S-4/A
BEARISH ★ 7/10
$11.99 $12.28▼ −2.42%▼ −1.82%$5.40 (+54.96%)
Aug 26, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$11.85 $11.99▲ +1.21%▲ +0.00%$5.40 (−54.42%)
Jun 11, 2026
19w ago
S-4/A
BEARISH ★ 6/10
$11.89 $11.96▼ −0.59%▲ +1.30%$5.40 (+54.58%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (11h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 18, 2026